Earnings Feed
Start Free
Caris Life Sciences, Inc.·4

Jan 13, 6:37 PM ET

CASTLEMAN PETER M 4

4 · Caris Life Sciences, Inc. · Filed Jan 13, 2026

Insider Transaction Report

Form 4
Period: 2026-01-09
Caris Life Sciences, Inc.CAI
CASTLEMAN PETER M
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-09$18.60/sh+2,500$46,500→ 18,629 total
  • Exercise/Conversion

    Stock Option

    [F2]
    2026-01-09−2,500→ 0 total
    Exercise: $18.60Exp: 2035-02-27→ Common Stock (2,500 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    100,000

  • Common Stock

    [F1]
    (indirect: By LLC)
    10,270,906
Footnotes (2)
  • [F1]CLS-PF-SPE Manager, LLC is the manager of CLS-PF-SPE, LLC. Mr. Castleman is a manager of CLS-PF-SPE Manager, LLC and in such capacity has voting and investment power with respect to the shares held by CLS-PF-SPE, LLC. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
  • [F2]The stock option is fully vested and exercisable. These securities were previously reported on the Reporting Person's Form 3.
Signature
/s/ J. Russel Denton, Attorney-in-Fact|2026-01-13

Documents

1 file
  • 4
    wk-form4_1768347427.xmlPrimary

    FORM 4